Risk of alanine aminotransferase flare in patients with previous hepatitis B virus exposure on biological modifier therapies-A population-based studyArticle Published on 2023-03-012023-06-11 Journal: Liver international : official journal of the Inte [Category] B형 간염, [키워드] ALT flare biological therapies past HBV infection. [DOI] 10.1111/liv.15499
Immunogenicity of the hepatitis B vaccine adjuvanted with AS04C in patients with biological therapiesArticle Published on 2023-01-162023-06-11 Journal: Vaccine [Category] B형 간염, [키워드] biological therapies Fendrix® Hepatitis B virus Immunomodulatory therapies vaccination Vaccine [DOI] 10.1016/j.vaccine.2022.12.009
Continuous effectiveness and safety after a hospital‐wide switch to adalimumab biosimilar: An observational study in rheumatoid arthritis patientsOriginal Article Published on 2022-12-082024-09-04 Journal: Pharmacology Research & Perspectives [Category] 대상포진, [키워드] adalimumab biological therapies Biosimilar Disease activity rheumatoid arthritis switch [DOI] 10.1002/prp2.1025 PMC 바로가기 [Article Type] Original Article
The effect of 24-week belimumab treatment withdrawal followed by treatment restart in patients with SLE: an open-label, non-randomised 52-week studyResearch Article Published on 2022-02-162024-09-02 Journal: Arthritis Research & Therapy [Category] 대상포진, [키워드] B cells biological therapies Biomarkers Lymphocytes Systemic lupus erythematosus and autoimmunity [DOI] 10.1186/s13075-022-02723-y PMC 바로가기 [Article Type] Research Article
Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from DenmarkObservational Study Published on 2021-10-092022-10-05 Journal: Rheumatology (Oxford, England) [Category] SARS, 임상, [키워드] acute respiratory distress adjusted Admitted Patient association biological therapies cohort study connective tissue COVID-19 COVID-19 hospitalization death Denmark disease DMARDs Epidemiology General population glucocorticoid Glucocorticoids HCQ higher risk Hospitalization hospitalized patient immunosupressants incidence incidence of COVID-19 individuals Inflammatory intensive care not affect outcome Patient rheumatoid arthritis risk Severe COVID-19 Infection spondyloarthritis syndrome treated viruses with COVID-19 [DOI] 10.1093/rheumatology/keaa897 PMC 바로가기 [Article Type] Observational Study
Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19Article Published on 2020-10-012023-07-06 Journal: Rheumatology International [Category] SARS, [키워드] biological therapies COVID-19 DMARDs immunosuppressants Paediatric rheumatology. [DOI] 10.1007/s00296-020-04663-9 PMC 바로가기
Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in SwitzerlandOriginal article Published on 2020-05-052024-09-04 Journal: RMD open [Category] 대상포진, [키워드] abatacept biological therapies comparative effectiveness research rheumatoid arthritis Tocilizumab tumour necrosis alpha inhibitors [DOI] 10.1136/rmdopen-2020-001174 PMC 바로가기 [Article Type] Original article
Safety and efficacy of infliximab in the treatment of refractory uveoretinitis in Behçet’s disease: a large-scale, long-term postmarketing surveillance in JapanResearch Article Published on 2019-01-052024-09-02 Journal: Arthritis Research & Therapy [Category] 대상포진, [키워드] Associated factor Behçet’s disease biological therapies Efficacy infliximab Postmarketing surveillance Safety Uveoretinitis [DOI] 10.1186/s13075-018-1793-7 PMC 바로가기 [Article Type] Research Article